# Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

> **NCT00100945** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 70 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** gefitinib

## Key facts

- **NCT ID:** NCT00100945
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-08
- **Final completion:** 2009-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100945, "Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00100945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*